Not FDA-approved
Bones & muscles
TB-500
Evidence
No human approvals
Class
Fragment of thymosin beta-4
KEY TAKEAWAY
TB-500 is a synthetic fragment of thymosin beta-4, a protein involved in cell movement and tissue repair. It has been studied in animals and is not approved for human use.
Written by the Veylo editorial team · Updated
November 2026
What it is
A synthetic piece of thymosin beta-4
Studied for
Tissue repair and cell migration in animal models
Key fact
Promoted healing in animal wound and heart injury models; no approved human use
Route
Injection (research use)
Evidence strength
No human approvals
TB-500 is sold as a research compound based on the active region of thymosin beta-4, a protein found in most human cells.
Thymosin beta-4 binds actin and appears to help cells migrate to damaged areas and form new blood vessels.
TB-500 is not approved by the FDA and is prohibited by the World Anti-Doping Agency.
Studied in animals for wound, muscle and cardiac repair. It has no approved medical use.
Human safety data are very limited. Risks of long-term use are not known.
Primary literature for this entry is being compiled.
Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.